Biotechnologies Assets SA (BST.MC)

EUR 0.3

(-2.6%)

Operating Income Summary of Biotechnologies Assets SA

Biotechnologies Assets SA's latest annual operating income in 2023 was 2.65 Million EUR , up 53.51% from previous year.
Biotechnologies Assets SA's latest quarterly operating income in 2023 FY was 2.65 Million EUR , up 53.51% from previous quarter.
Biotechnologies Assets SA reported an annual operating income of 1.72 Million EUR in 2022, up 183.38% from previous year.
Biotechnologies Assets SA reported an annual operating income of -2.07 Million EUR in 2021, down -71.56% from previous year.
Biotechnologies Assets SA reported a quarterly operating income of 1.54 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Biotechnologies Assets SA reported a quarterly operating income of -221.9 Thousand EUR for 2023 Q3, down -114.33% from previous quarter.

Annual Operating Income Chart of Biotechnologies Assets SA (2023 - 2010)

Historical Annual Operating Income of Biotechnologies Assets SA (2023 - 2010)

Year	Operating Income	Operating Income Growth
2023	2.65 Million EUR	53.51%
2022	1.72 Million EUR	183.38%
2021	-2.07 Million EUR	-71.56%
2020	-1.2 Million EUR	81.99%
2019	-6.7 Million EUR	55.11%
2018	-14.94 Million EUR	-5565.39%
2017	-263.82 Thousand EUR	84.22%
2016	-1.67 Million EUR	-183.85%
2015	-588.94 Thousand EUR	-277.61%
2014	331.6 Thousand EUR	51.68%
2013	218.62 Thousand EUR	128.68%
2012	-762.3 Thousand EUR	-913.26%
2011	-75.23 Thousand EUR	-24.37%
2010	-60.49 Thousand EUR	0.0%

Year	Operating Income	Operating Income Growth
2023 FY	2.65 Million EUR	53.51%
2023 Q2	1.54 Million EUR	0.0%
2023 Q3	-221.9 Thousand EUR	-114.33%
2023 Q1	1.54 Million EUR	811.12%
2023 Q4	-221.9 Thousand EUR	0.0%
2022 FY	1.72 Million EUR	183.38%
2022 Q4	-217.81 Thousand EUR	0.0%
2021 FY	-2.07 Million EUR	-71.56%
2020 FY	-1.2 Million EUR	81.99%
2019 FY	-6.7 Million EUR	55.11%
2018 FY	-14.94 Million EUR	-5565.39%
2017 FY	-263.82 Thousand EUR	84.22%
2016 FY	-1.67 Million EUR	-183.85%
2015 FY	-588.94 Thousand EUR	-277.61%
2014 FY	331.6 Thousand EUR	51.68%
2013 FY	218.62 Thousand EUR	128.68%
2012 FY	-762.3 Thousand EUR	-913.26%
2011 FY	-75.23 Thousand EUR	-24.37%
2010 FY	-60.49 Thousand EUR	0.0%

Peer Operating Income Comparison of Biotechnologies Assets SA

Name	Operating Income	Operating Income Difference
Atrys Health, S.A.	-1.58 Million EUR	267.764%
Oryzon Genomics S.A.	-4.54 Million EUR	158.341%
Pharma Mar, S.A.	-3.82 Million EUR	169.35%
Laboratorios Farmaceuticos Rovi, S.A.	220.25 Million EUR	98.795%